A detailed history of First Financial Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, First Financial Corp holds 12,350 shares of MRK stock, worth $1.26 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
12,350
Previous 12,435 0.68%
Holding current value
$1.26 Million
Previous $1.54 Million 8.9%
% of portfolio
0.67%
Previous 0.79%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$111.15 - $128.97 $9,447 - $10,962
-85 Reduced 0.68%
12,350 $1.4 Million
Q2 2024

Jul 11, 2024

SELL
$123.8 - $132.96 $26,493 - $28,453
-214 Reduced 1.69%
12,435 $1.54 Million
Q1 2024

Apr 12, 2024

SELL
$113.24 - $131.95 $290,007 - $337,923
-2,561 Reduced 16.84%
12,649 $1.67 Million
Q4 2023

Jan 16, 2024

SELL
$100.18 - $109.02 $21,137 - $23,003
-211 Reduced 1.37%
15,210 $1.66 Million
Q3 2023

Oct 11, 2023

BUY
$102.95 - $114.33 $568,798 - $631,673
5,525 Added 55.83%
15,421 $1.59 Million
Q2 2023

Jul 14, 2023

SELL
$108.61 - $118.38 $1,303 - $1,420
-12 Reduced 0.12%
9,896 $1.14 Million
Q1 2023

Apr 17, 2023

SELL
$102.94 - $114.86 $50,131 - $55,936
-487 Reduced 4.68%
9,908 $1.05 Million
Q1 2022

Apr 14, 2022

BUY
$73.51 - $82.4 $7,351 - $8,240
100 Added 0.97%
10,395 $852,000
Q3 2021

Oct 18, 2021

SELL
$71.68 - $78.83 $18,135 - $19,943
-253 Reduced 2.4%
10,295 $773,000
Q1 2021

Apr 15, 2021

SELL
$68.86 - $81.11 $9,502 - $11,193
-138 Reduced 1.29%
10,548 $813,000
Q4 2020

Jan 15, 2021

SELL
$71.77 - $79.65 $16,148 - $17,921
-225 Reduced 2.06%
10,686 $874,000
Q3 2020

Oct 13, 2020

BUY
$73.18 - $82.95 $37,614 - $42,636
514 Added 4.94%
10,911 $905,000
Q2 2020

Jul 15, 2020

SELL
$70.42 - $80.13 $5,351 - $6,089
-76 Reduced 0.73%
10,397 $804,000
Q1 2020

Apr 15, 2020

BUY
$63.36 - $87.82 $5,702 - $7,903
90 Added 0.87%
10,473 $806,000
Q4 2019

Jan 15, 2020

SELL
$77.58 - $87.54 $11,637 - $13,131
-150 Reduced 1.42%
10,383 $945,000
Q3 2019

Oct 15, 2019

BUY
$76.08 - $82.93 $32,714 - $35,659
430 Added 4.26%
10,533 $887,000
Q2 2019

Jul 15, 2019

SELL
$69.84 - $81.59 $6,984 - $8,159
-100 Reduced 0.98%
10,103 $847,000
Q1 2019

Apr 12, 2019

BUY
$69.58 - $79.36 $10,437 - $11,904
150 Added 1.49%
10,203 $848,000
Q4 2018

Jan 15, 2019

SELL
$65.24 - $75.71 $28,379 - $32,933
-435 Reduced 4.15%
10,053 $768,000
Q3 2018

Oct 16, 2018

SELL
$57.69 - $67.84 $24,806 - $29,171
-430 Reduced 3.94%
10,488 $744,000
Q2 2018

Jul 12, 2018

SELL
$50.83 - $59.72 $4,320 - $5,076
-85 Reduced 0.77%
10,918 $663,000
Q1 2018

Apr 17, 2018

SELL
$50.96 - $59.23 $35,722 - $41,520
-701 Reduced 5.99%
11,003 $600,000
Q4 2017

Jan 16, 2018

SELL
$51.62 - $61.64 $34,017 - $40,620
-659 Reduced 5.33%
11,704 $659,000
Q3 2017

Oct 13, 2017

BUY
$58.67 - $63.13 $725,337 - $780,476
12,363
12,363 $792,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $258B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track First Financial Corp Portfolio

Follow First Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Financial Corp , based on Form 13F filings with the SEC.

News

Stay updated on First Financial Corp with notifications on news.